An RSNA attendee registers for the National Oncologic PET Registry (NOPR), which began accepting preregistration at the Chicago meeting.
The registry is part of a compromise agreement between PET imaging proponents and the Centers for Medicare and Medicaid to enable Medicare to expand coverage to most PET cancer imaging procedures. The only such procedures excluded from coverage are initial breast cancer diagnosis, breast cancer initial staging to evaluate axillary lymph nodes, and melanoma staging to evaluate regional lymph nodes.
Although formal registration will commence at a later date, preregistration will get facilities started on the process, said Dr. Barry Siegel, cochair of the NOPR working group.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.